» Articles » PMID: 9262495

The Effect of Calcium Supplementation on Bone Density During Lactation and After Weaning

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1997 Aug 21
PMID 9262495
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Women may lose bone during lactation because of calcium lost in breast milk. We studied whether calcium supplementation prevents bone loss during lactation or augments bone gain after weaning.

Methods: We conducted two randomized, placebo-controlled trials of calcium supplementation (1 g per day) in postpartum women. In one trial (the study of lactation), 97 lactating and 99 nonlactating women were enrolled a mean (+/-SD) of 16+/-2 days post partum. In the second trial (the study of weaning), 95 lactating women who weaned their infants in the 2 months after enrollment and 92 nonlactating women were enrolled 5.6+/-0.8 months post partum. The bone density of the total body, lumbar spine, and forearm was measured at enrollment and after three and six months.

Results: The bone density of the lumbar spine decreased by 4.2 percent in the lactating women receiving calcium and by 4.9 percent in those receiving placebo and increased by 2.2 and 0.4 percent, respectively, in the nonlactating women (P<0.001 for the effect of lactation; P= 0.01 for the effect of calcium). After weaning, the bone density of the lumbar spine increased by 5.9 percent in the lactating women receiving calcium and by 4.4 percent in those receiving placebo; it increased by 2.5 and 1.6 percent, respectively, in the nonlactating women (P<0.001 for the effects of lactation and calcium). There was no effect of either lactation or calcium supplementation on bone density in the forearm, and there was no effect of calcium supplementation on the calcium concentration in breast milk.

Conclusions: Calcium supplementation does not prevent bone loss during lactation and only slightly enhances the gain in bone density after weaning.

Citing Articles

[Pregnancy and lactation-associated osteoporosis: risk factors and treatment].

Warnecke K, Muche B, Krause A, Hoff P Z Rheumatol. 2025; 84(2):121-127.

PMID: 39976715 DOI: 10.1007/s00393-025-01619-x.


Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes.

Kongwattanakul K, Duangkum C, Ngamjarus C, Lumbiganon P, Cuthbert A, Weeks J Cochrane Database Syst Rev. 2024; 11:CD007079.

PMID: 39560075 PMC: 11574946. DOI: 10.1002/14651858.CD007079.pub4.


Second Child After Pregnancy and Lactation-Related Osteoporosis (PLO) Treated With Teriparatide: A Case Report.

Yamada S, Hayashi N, Toi N, Miyaoka D, Hashimoto M Cureus. 2024; 16(7):e64900.

PMID: 39156353 PMC: 11330588. DOI: 10.7759/cureus.64900.


Connexin hemichannels drive lactation-induced osteocyte acidification and perilacunar-canalicular remodeling.

Hua R, Truong V, Fajardo R, Guda T, Gu S, Jiang J Cell Rep. 2024; 43(7):114363.

PMID: 38935505 PMC: 11318086. DOI: 10.1016/j.celrep.2024.114363.


Pregnancy and lactation-associated osteoporosis as a major type of premenopausal osteoporosis: a retrospective cohort study based on real-world data.

Kasahara K, Tanaka-Mizuno S, Tsuji S, Ohashi M, Kasahara M, Kawasaki T BMC Pregnancy Childbirth. 2024; 24(1):301.

PMID: 38649869 PMC: 11034016. DOI: 10.1186/s12884-024-06520-0.